Alpha Cognition Inc.
ACOG · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 4 ·
Latest disclosures
-
Opaleye Management Inc.: Form 4
Insider disclosure · Filed · Report period 15 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ACOG · 02074J501 - Common Stock, no par value
Company details and SEC sources
CIK 0001655923 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ACOG on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 1452 Hughes Rd., Ste. 200, Grapevine, TX, 76051
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- 31 December
- Former names on EDGAR
- Neurodyn Cognition Inc. (to 09 Oct 2019)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields